Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

NCT: NCT07158970 · RECRUITING

NCT IDNCT07158970
StatusRECRUITING
Start Date2026-03-01
Completion2027-11-01
SponsorWolfson Medical Center (OTHER_GOV)
First posted
Last updated

Brief Summary

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Frequently Asked Questions

What is Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)?

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM) is a clinical trial registered under NCT07158970. Current status: RECRUITING.

What is the status of NCT07158970?

The current status of NCT07158970 (Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)) is: RECRUITING.

When did Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM) start?

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM) started on 2026-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑